Showing results (61-70 of 1,983) with videos related to
Sort By:
Pageof 199
Breast (Edinburgh, Scotland)|August 2, 2020
Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancerHongnan Mo, Xiaobing Wang, Fei Ma, et al.Therapeutic Advances in Medical Oncology|June 19, 2025
The characteristics of HER2-positive microinvasive breast cancer and the necessity of systemic adjuvant therapy in these patients: a multicenter real-world studyBo Lan, Dan Lv, Changyuan Guo, et al.Medicine|July 2, 2015
Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast CancerJiayu Wang, Binghe Xu, Peng Yuan, et al.Cancer Biology & Therapy|October 16, 2015
A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanesQiao Li, Qing Li, Pin Zhang, et al.Cancer Research and Treatment|January 14, 2026
Pre-Treatment Ki67 Index for Everolimus Efficacy in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter Cohort StudyYujing Tan, Hanfang Jiang, Fei Ma, et al.Ebiomedicine|October 5, 2024
Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: insights from the PHILA trialShuning Liu, Bo Lan, Yuanyi Wang, et al.Cancer Letters|August 19, 2014
Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)Fei Ma, Huihui Li, Haijuan Wang, et al.Oncology Letters|June 13, 2019
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational studyAnjie Zhu, Peng Yuan, Jiayu Wang, et al.Chinese Medical Journal|August 19, 2022
Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han populationHongnan Mo, Fei Ma, Qing Li, et al.Clinical Breast Cancer|September 12, 2018
Distinct Characteristics and Metastatic Behaviors of Late Recurrence in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: A Single Institute Experience of More Than 10 YearsXuelian Chen, Ying Fan, Binghe XuPageof 199